CONSORT diagram: NSABP Protocols B-30, B-31, B-34, and B-38. BC

Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis

Frontiers Breast-conserving surgery versus mastectomy for treatment of breast cancer after neoadjuvant chemotherapy

National Surgical Adjuvant Breast and Bowel Project (NSABP)

HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer. - Abstract - Europe PMC

Frontiers Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II

Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D) - ScienceDirect

Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial. - Abstract - Europe PMC

Comparison of Breast Cancer Recurrence and Outcome Patterns Between Patients Treated From 1986 to 1992 and From 2004 to 2008

View of Abemaciclib (Verzenio) Canadian Journal of Health Technologies